Menarini Asia-Pacific is pleased to announce the appointment of its new Chief Executive Officer, Mr. Glen Godresse, effective from March 1st, 2024.
Glen brings over 25 years of pharmaceutical industry experience and since joining Menarini in 2013, Glen has held several senior leadership positions at the Company including General Manager of Australia and New Zealand and Regional Chief Marketing Officer.
Under Glen’s leadership, Menarini Asia-Pacific will continue investing and nurturing its proprietary and partnered brands through its flexible omnichannel commercialization model, while simultaneously addressing unmet patient needs, in the broad array of developed and emerging markets and therapeutic areas in which it competes.
In tandem with this transition, Mr. Maurizio Luongo will be repatriating to Florence, Italy to assume a position at Menarini Group as Chief Operating Officer of Emerging Markets (Asia-Pacific, Latin America, Turkey, Middle East and Africa) and Global Medical Marketing Pharmaceuticals. In his new remit, he will still be providing oversight to the region. Both appointments have taken effect concurrently on 1 March 2024.
